Search Results 321-330 of 17253 for peptide combinations
The purpose of this study is the safety, tolerability, and preliminary antitumor activity of ziftomenib in combination with imatinib will be evaluated in ...
Unlike octreotide or lanreotide, which are peptides, paltusotine is not a peptide. ... peptide medicines. Somatostatins are the first line treatment for ...
Led by Mayo Clinic, researchers found that ibrutinib and chemotherapy (bendamustine and rituximab, known as BR) reduced the risk of death or cancer progression ...
Rochester, Minn. This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard ...
Rochester, Minn. The purpose of this study is to evaluate how well the combination of avelumab with liposomal doxorubicin with or without binimetinib, or the ...
Durvalumab in combination with chemotherapy before surgery may enhance the shrinking of the tumor compared to chemotherapy alone. A Study to Evaluate RP1 ...
The benefit of the combination with androgen suppression is not completely understood. This study will compare the use of hypofraction proton therapy (28 ...
... combination with Nab-P + GEM, determine overall survival and assess the safety and tolerability of the combination treatment. This study will also evaluate ...
... combinations) with particular tumor profiles. Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell ...
Giving ascorbic acid and combination chemotherapy may work better at treating lymphoma. In the Clonal Cytopenia of Undetermined Significance (CCUS) Cohort D, we ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!